
A | Kuala Lumpur, Oct 10 (UNI) Malaysian Prime Minister Ismail Sabri Yaakob announced the dissolution of the country's parliament on Monday, paving the way for national elections which must be held in the next 60 days.
In a televised speech, Ismail Sabri said he had received the consent of the country's King Sultan Abdullah Sultan Ahmad Shah in accordance with the country's constitution.
Ismail Sabri said the past years have seen several unprecedented developments after the national elections in 2018, including political uncertainties with the changes of several prime ministers and the Covid-19 pandemic, which together have harmed the country's socio-economic and political situation.
"With this announcement, the mandate will be returned to the people. The people's mandate is a powerful antidote for the country to restore political stability and create a government which is firm, stable and respected after the elections," he said.
The date of polling day is yet to be announced by the Election Commission of Malaysia. Normally, a general election should be held no later than two months after the dissolution of the parliament. Voters will elect the 222-member Dewan Rakyat, or the House of Representatives.
The possibility of national elections have been hotly discussed over recent months with United Malays National Organization (UMNO), the biggest party in the ruling coalition, calling for elections to end the political uncertainty which has seen two prime ministers appointed since 2020 following the resignation of former prime minister Mahathir Mohamad in February of that year.
Muhyiddin Yassin was sworn in as the prime minister on March 1, 2020 but later resigned following the withdrawal of support by members of parliament from his own coalition. Ismail Sabri was then appointed as the prime minister on August 21, 2021.
UNI/XINHUA PRT。1月15日*圣昌盛(002680)1月14日晚宣布。1月14日,深圳证券交易所收到《关于实施长胜生物科技有限公司重大违法强制退市的决定》,1月15日,深圳证券交易所股票继续停牌一天,1月16日恢复交易。自复牌之日起,深圳证券交易所将继续对公司股票交易实施回避风险警示。退出市场的风险预警期为30个交易日。

B | 30个交易日后有暂停上市的风险。根据该决定的内容,公司主要子公司长春长胜生物科技有限公司于2018年10月16日因疫苗生产违法违规被药品监督管理部门吊销药品生产许可证,处以91亿元以下的罚款。上述违法行为危害公共卫生安全,严重损害国家和社会公共利益。涉及《深圳证券交易所上市公司重大违法强制退市实施办法》第二条、第五条规定的重大违法强制退市情况。
Current article:http://aek97.cengzaodengchawonin.cyou/3wj/20260826/738.html
Published on:00:00:00
关于我们 | 我的网站 版权所有
Copyright ? 2019 我的网站 All Rights Reserved